| |
FOR IMMEDIATE RELEASE
Contact:
Jim Parina
724-935-7029
jparina@expressionanalysis.com
Expression Analysis Adopts NuGEN’s Ovation™ System for Small-Sample Amplification
Durham, N.C. (September 26, 2006) — Expression Analysis, Inc., the industry’s leading provider of Affymetrix GeneChip® brand microarray services for clinical trials, announced today that it has adopted NuGEN Technologies’ Ovation™ System family of products for amplification, fragmentation and labeling of samples with limited quantities of total RNA for GeneChip microarray analysis.
”Our validation of the Ovation™ System utilized the same RNA samples tested in the Microarray Quality Control Project and employed many of the same analysis methods. Our assessment indicated that the data was excellent and superior in quality relative to that generated using two cycles of in vitro transcription,” commented Dr. Tom Goralski, Senior Director of Laboratory Operations at Expression Analysis. “We hope to migrate all of our clients who require microarray testing with limited RNA specimens to this service. We will continue to evaluate the Ovation™ System for potential use with whole blood samples.”
Expression Analysis, Inc. also announced that it will begin to validate the new WT-Ovation™ Pico RNA Amplification System for ultra-small and/or degraded specimens in early October. “We believe this product may be extremely useful in tumor-based oncology applications,” continued Dr. Goralski.
“Adoption of the Ovation™ platform by Expression Analysis speaks to the value of NuGEN’s technology for laboratories involved in high throughput work with valuable and limited samples, especially in the area of oncology research,” said Dr. Sue Pandey, Vice President of Commercial Operations at NuGEN Technologies. “We are extremely pleased to be working with Expression Analysis.”
About Expression Analysis, Inc.
Expression Analysis, Inc. (http://www.expressionanalysis.com) is the industry’s leading provider of Affymetrix GeneChip®: brand microarray services for clinical trials. Specializing in gene expression, genotyping and resequencing, the Company became the first GLP compliant microarray processing laboratory in the world. The Company provides start to finish microarray contract testing offering high throughput, high quality and cost-effective results in a regulatory compliant environment to advance genomic science.
About NuGEN Technologies Inc.
NuGEN Technologies, based in San Carlos, CA, is focused on the development and commercialization of sensitive, rapid and high-throughput amplification and detection systems to enable the comprehensive analysis and discovery of biological mechanisms, cellular responses, and disease pathologies. For more information, visit www.nugeninc.com.
|
|
